METTL14 and acute myeloid leukemia: Taken together, above findings suggests Mettl14 in combination with various differentiation-inducing agents such as ATRA could be a promising approach to control AML with the other forms of therapeutic approaches (radio/chemo/BM-transplantation) [49], (Figure 2, Table 2).